Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/25/22
End: 12/31/25
Due: 12/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma | NCT05422027 | Xia Zhongjun | user2@example.com | None | 2022-07-25 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |